Arbutus Biopharma Aktie
3,78
EUR
-0,11
EUR
-2,88
%
4,44
USD
-0,17
USD
-3,69
%
Werbung
Arbutus Biopharma Aktie Analyse
| 15.10.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
| 06.07.18 | Arbutus Biopharma Neutral | B. Riley FBR, Inc. | |
| 19.03.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
| 13.12.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
| 14.10.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
| 16.06.16 | Arbutus Biopharma Neutral | Chardan Capital Markets |
Werbung
Werbung